drugset / Trial / NCT02445352
Efficacy/Safety of DP-R207 Tablet Versus CRESTOR Tablet in Patients With Primary Hypercholesterolemia
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to evaluate efficacy and safety of DP-R207 in patients with primary hypercholesterolemia.
Timeline
- Start
- 2014-07
- Primary completion
- 2015-01
- Completion
- 2015-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ezetimibe | Unknown | 10 mg | — |
| Comparator | Rosuvastatin | Small molecule | 5 mg | — |
| Comparator | Rosuvastatin | Small molecule | 10 mg | — |
| Comparator | Rosuvastatin | Small molecule | 20 mg | — |